Stay updated on Quadruplet Induction & Transplant in Myeloma Clinical Trial

Sign up to get notified when there's something new on the Quadruplet Induction & Transplant in Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Quadruplet Induction & Transplant in Myeloma Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-13T21:52:42.000Z thumbnail image
  4. Check
    3 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value 7 has recently changed to 8 on the webpage, indicating an update in the ongoing clinical trial study for an intensive program with quadruplet induction and consolidation plus tandem autologous stem cell transplantation in newly diagnosed high-risk multiple myeloma patients. This change reflects a modification in the treatment protocol involving carfilzomib, lenalidomide, dexamethasone, and daratumumab for the participants.
    Difference
    0.1%
    Check dated 2024-06-06T14:25:55.000Z thumbnail image
  7. Check
    24 days ago
    Change Detected
    Summary
    The webpage has been updated to include detailed eligibility criteria for participation in the study, specifying age, consent requirements, and health conditions. Previously, no information was provided about the participation criteria.
    Difference
    51%
    Check dated 2024-05-22T21:26:50.000Z thumbnail image
  8. Check
    46 days ago
    Change Detected
    Difference
    0.8%
    Check dated 2024-04-30T22:40:12.000Z thumbnail image

Stay in the know with updates to Quadruplet Induction & Transplant in Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Quadruplet Induction & Transplant in Myeloma Clinical Trial page.